The significance of minimal residual disease (MRD) in relapsed childhood B-lymphoblastic leukemia (B-ALL): A report from Children’s Oncology Group (COG) protocol AALL0433.
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Emory University, Children's Oncology Group, CancerCare Manitoba, Children's Hospital of Philadelphia, Hospital for Sick Children, University of Utah, Children's Medical Center, The University of Texas Southwestern Medical Center, NYU Langone Health, Johns Hopkins University, University of Colorado Denver
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2762299287
